retatrutide peptide dosage schedule Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Dosing: What You Need

Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults

Breath testing evaluates fermentation, absorption, and intestinal motility

MetaVia is advancing therapies designed specifically for the next era of metabolic disease, where liver, cardiometabolic and inflammatory pathways converge

The alterations of SCFA composition and concentration are apparent in IBS patients (Tana et al., 2010

Abstract Aims/hypothesis Glucagon-like peptide 1 (GLP-1) agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors are novel drugs which have recently seen rapid uptake in the treatment of type 2 diabetes and obesity

Indikationen [Bearbeiten | Quelltext bearbeiten] Diabetes mellitus Typ 2 [Bearbeiten | Quelltext bearbeiten] Der primre Einsatzbereich der Inkretinmimetika ist die Therapie des Diabetes mellitus Typ 2